The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation
BackgroundCD46 has been revealed to be a key factor in malignant transformation and cancer treatment. However, the clinical significance of CD46 in cervical cancer remains unclear, and this study aimed to evaluate its role in cervical cancer diagnosis …